Literature DB >> 3050799

Macrophage activation in vitro by lymphocytes from Leishmania major infected healer and non-healer mice.

T V Pham1, H R MacDonald, J Mauël.   

Abstract

Peritoneal macrophages from CBA/T6 (healer) and BALB/c (non-healer) mice were infected with Leishmania major (LV39) in vitro. The microorganism replicated at the same rate in macrophages from either strain. Exposure of infected cells to lymph node cells (LNC) from infected syngeneic animals led to intracellular killing of the parasite by macrophages from both strains, provided LPS was present in the incubation medium. In vitro-propagated L.major-specific T-cell blasts activated macrophages from either strain in the absence of LPS. On a per cell basis, lymphoid cells from BALB/c mice were less efficient, however, than cells from CBA/T6 mice. Lysis of parasitized macrophages was also more marked in CBA/T6 than in BALB/c cell mixtures. LNC exposed to parasite antigen or to infected macrophages secreted macrophage-activating factor (MAF); incubation with antigen also induced lymphocyte proliferation. MAF production and LNC proliferation decreased with progression of the infection of BALB/c mice, but always remained significant. The reduction in relative T-cell numbers in the lymph nodes of infected animals was moderate; the absolute number of T-cells increased markedly in the lymphoid organs of both strains, however. These results suggest that failure to heal may coexist together with active cell-mediated immune response in non-healer mice.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3050799     DOI: 10.1111/j.1365-3024.1988.tb00226.x

Source DB:  PubMed          Journal:  Parasite Immunol        ISSN: 0141-9838            Impact factor:   2.280


  1 in total

1.  Influence of the culture medium on the production of nitric oxide and expression of inducible nitric oxide synthase by activated macrophages in vitro.

Authors:  Tomoya Kawakami; Kana Kawamura; Ko Fujimori; Atsushi Koike; Fumio Amano
Journal:  Biochem Biophys Rep       Date:  2016-01-13
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.